Evidence map›Paper›PMID 32128335›Full record

ArticleOpen forum infectious diseases2019

Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient.

Rosy Priya L Kodiyanplakkal, Jennifer M Laplante, Lars F Westblade, Koen van Besien, Mirella Salvatore, Kirsten St George

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Practical updates in clinical antiviral resistance testing.Journal of clinical microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Rosy Priya L KodiyanplakkalDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Jennifer M LaplanteLaboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Lars F WestbladeDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Koen van BesienDivision of Hematology Oncology, Weill Cornell Medicine, New York, New York, USA.
Mirella SalvatoreDivision of Public Health Programs, Weill Cornell Medicine, New York, New York, USA.
Kirsten St GeorgeLaboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Cornell University · USNew York State Department of Health · USWadsworth Center · USWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiviral-resistant influenza viruses in the clinical environment, especially type B, are reported rarely. A stem cell transplant recipient remained influenza B positive for 2 months, despite repeated antiviral treatments. Laboratory tests demonstrated the evolution and persistence of neuraminidase inhibitor-resistant influenza B virus with a substitution at codon 119.

Indexed as

antiviral resistanceinfluenza B virusneuraminidase inhibitorsneuraminidase mutationstem cell transplant

Identifiers

PMID32128335
PMCPMC7047943
OpenAlexW2988687498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.